简体
简体中文
繁體中文

DataMEDS AI MEDS 深 沪

等待开盘 10-06 09:30:00 美东时间

3.35

-0.330

-8.97%

华盛通华盛通
立即下载
  • 最 高12.31
  • 今 开3.55
  • 成交量 60.44万股
  • 最 低 0.8225
  • 昨 收 3.68
  • 总市值 2740.64万
  • 52周最高 43.06
  • 市盈率 静 --
  • 换手率 0.01%
  • 52周最低 0.8225
  • 委 比 -71.16%
  • 总股本 818.10万
  • 历史最高 172.50
  • 量 比 0.05
  • 振 幅 312.16%
  • 历史最低 0.8225
  • 每 手 1
  • 风险率 1.45%

个股概要

财务分析

公司资料

相关新闻

分红派息

  • 分时图
  • 日k
  • 周k
  • 月k

相关新闻

更多
  • DataMeds AI Stock Surges on Mobile App Launch

    DataMeds AI shares are surging Monday after launching a “Health Lives Here” mobile app with Tollo Health and the NFL Alumni Association.

    09-28 22:59

  • 12 Health Care Stocks Moving In Monday's Pre-Market Session

    Gainers Kodiak Sciences (NASDAQ:KOD) shares increased by 57.4% to $50.93 during Monday's pre-market session. The market value of their outstanding shares is at $2.0 billion. Accuray (NASDAQ:ARAY) stock moved

    09-28 20:05

  • 礼来起诉四家药企仿制其减肥神药

      全球制药巨头礼来公司周三宣布,已对四家复合药厂提起法律诉讼,指控其非法生产并销售含有替尔泊肽(tirzepatide)的未经批准复合药物。复合药物是指通过混合、组合或改变药物成分制成的药物。   这是继上月美国法官禁止药房仿制其减肥药和糖尿病药物后,礼来在知识产权保护方面挥出的又一记重拳。   这四家被告公司分别是Mochi Health Corp、Fella Health and Delilah、Willow Health Services和Henry Meds。   礼来制药向加州法院对他们提起诉讼,主要指控其销售含有添加剂或口服剂型的替尔泊肽仿制药品,且无法提供安全性和有效性的临床证...

    2025-04-23 23:26

  • TRxADE Health, Inc. Announces Name Change To Scienture Holdings, Inc. And Ticker Symbol Change To "SCNX"

    TRxADE Health, Inc. today announced that it changed its name and ticker symbol to "Scienture Holdings, Inc." and "SCNX", respectively, and that the business will continue as a Nasdaq-listed company. TAMPA, FL, Sept.

    2024-09-24 20:29